Clinical trials
Phase 2 Hematologic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Completed | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Zhejiang University | 3 |
| Janssen Research & Development, LLC | 2 |
| Anhui Provincial Hospital | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 12 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Leukemia, B-Cell | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Lymphopenia | 1 |
| Multiple Myeloma | 1 |
| Recurrence | 1 |
| Waldenstrom Macroglobulinemia | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.